Tami Tillotson Martin

Insider Reports History

Location
Rockville, MD
Signature
/s/ Timothy C. Dec, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tami Tillotson Martin:

Company Role Class Num Shares Value Price $ Report Date Ownership
SUPERNUS PHARMACEUTICALS, INC. Sr. V.P., Regulatory Affairs Common Stock 86,933 $2,526,273 $29.06 23 Feb 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. Sr. V.P., Regulatory Affairs Restricted Stock Unit 3,750 $104,775 $27.94 23 Feb 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. Sr. V.P., Regulatory Affairs Employee Stock Option (Right to Buy) 0 10 Jan 2024 Direct

Insider Reports Filed by Tami Tillotson Martin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SUPN SUPERNUS PHARMACEUTICALS, INC. 23 Feb 2024 3 -$14,094 4 Sr. V.P., Regulatory Affairs 27 Feb 2024, 17:00
SUPN SUPERNUS PHARMACEUTICALS, INC. 22 Feb 2024 3 -$6,873 4 Sr. V.P., Regulatory Affairs 26 Feb 2024, 17:00
SUPN SUPERNUS PHARMACEUTICALS, INC. 10 Jan 2024 3 -$149,360 4 Sr. V.P., Regulatory Affairs 12 Jan 2024, 17:00
SUPN SUPERNUS PHARMACEUTICALS, INC. 30 Aug 2023 3 -$64,881 4 Sr. V.P., Regulatory Affairs 01 Sep 2023, 17:00
SUPN SUPERNUS PHARMACEUTICALS, INC. 25 Aug 2023 1 -$162,215 4 Sr. V.P., Regulatory Affairs 29 Aug 2023, 17:00
SUPN SUPERNUS PHARMACEUTICALS, INC. 23 Feb 2023 2 $0 4 Sr. V.P., Regulatory Affairs 27 Feb 2023, 16:03
SUPN SUPERNUS PHARMACEUTICALS, INC. 22 Feb 2023 3 -$11,147 4/A Sr. V.P., Regulatory Affairs 12 Apr 2023, 17:00
SUPN SUPERNUS PHARMACEUTICALS, INC. 16 Feb 2023 2 $0 4 Sr. V.P., Regulatory Affairs 21 Feb 2023, 16:01
SUPN SUPERNUS PHARMACEUTICALS, INC. 12 Jan 2023 1 $0 4 Sr. V.P., Regulatory Affairs 17 Jan 2023, 16:02
SUPN SUPERNUS PHARMACEUTICALS, INC. 22 Aug 2022 3 -$140,400 4 Sr. V.P., Regulatory Affairs 23 Aug 2022, 17:16
SUPN SUPERNUS PHARMACEUTICALS, INC. 04 Aug 2022 3 -$125,400 4 Sr. V.P., Regulatory Affairs 05 Aug 2022, 16:31
SUPN SUPERNUS PHARMACEUTICALS, INC. 22 Feb 2022 2 $0 4/A Sr. V.P., Regulatory Affairs 25 Feb 2022, 16:17